Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 77.87K 72.13K 65.58K 123K 8.28M 125K 865K 340K 4.33M 328K 321K 13.84M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 219M 203M 185M 346M 23.3B 352M 2.43B 957M 12.18B 922M 903M 38.93B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-1.33%+4.88%+54.50%+109.94% 1,106B
-0.69%-3.77%+31.35%+66.62% 612B
-0.96%+0.55%+23.13%+94.26% 500B
+1.50%+7.06%+37.03%+61.17% 367B
-1.59%-1.25%+69.39%+43.02% 354B
+0.48%+4.63%+19.86%+47.19% 286B
+0.61%+4.91%-0.67%+19.65% 256B
-1.75%+1.76%+42.21%+51.44% 230B
-2.00%+1.75%+24.64%+95.14% 190B
Average -0.57%+1.91%+33.49%+65.38% 390.01B
Weighted average by Cap. -0.74%+2.30%+38.22%+75.77%

Financials

2016 2017
Net sales 54.27M 48.38M 44.81M 40.75M 76.46M 5.15B 77.71M 537M 211M 2.69B 204M 199M 8.6B 106M 94.44M 87.48M 79.54M 149M 10.04B 152M 1.05B 413M 5.25B 398M 389M 16.78B
Net income -103M -91.79M -85.03M -77.31M -145M -9.76B -147M -1.02B -401M -5.1B -386M -378M -16.31B -125M -112M -103M -94M -176M -11.87B -179M -1.24B -488M -6.2B -470M -460M -19.83B
Net Debt 209M 187M 173M 157M 295M 19.86B 300M 2.07B 816M 10.38B 786M 770M 33.19B 246M 219M 203M 184M 346M 23.29B 352M 2.43B 957M 12.17B 922M 902M 38.91B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock